Opus Genetics IRD
NASDAQ IRD
$4.41 +0.18 (+4.14%)
As of: Nov 11, 2026 · 1:00 PM EST

Opus Genetics (IRD) Interest Coverage Ratio (2009 - 2026)

Updated

Opus Genetics' Interest Coverage Ratio was -208.17 in Q1 2026.

Analysis

Opus Genetics (IRD) Interest Coverage Ratio (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Opus Genetics' Interest Coverage Ratio was -217.34 through Mar 31, 2026; for FY2025, it came in at -299.22.

  • In earlier years, Interest Coverage Ratio was 2025.11 in FY2022 and -11352.50 in FY2021.
  • The Q1 2026 figure marks the lowest quarterly Interest Coverage Ratio since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 28.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.20
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 5.68
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 12.87
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Opus Genetics 405.23 Mn 122.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -31.04
Mar 31, 2026 -28.00
Dec 31, 2025 -187.75
Sep 30, 2025 -122.22
Jun 30, 2025 -254.46
Mar 31, 2025 -7.24
Sep 30, 2023 4.81
Jun 30, 2022 -1,234.50
Mar 31, 2022 -1,301.60
Dec 31, 2021 -3,075.00
Dec 31, 2020 -2.58
Sep 30, 2020 -10.88
Jun 30, 2020 -1.83
Mar 31, 2020 -4.94
Dec 31, 2017 -22.31
Jun 30, 2017 -12.86
Sep 30, 2016 -25.96
Mar 31, 2016 -28.63
Mar 31, 2014 -5.45
Dec 31, 2013 -4.57
API Access

Opus Genetics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=IRD&period=max&api_key=YOUR_API_KEY